Total Payments
$29,192
2024 Payments
$150.00
Companies
10
Transactions
30
Medicare Patients
1,699
Medicare Billing
$203,353
Payment Breakdown by Category
Consulting$22,578 (77.3%)
Other$4,170 (14.3%)
Travel$1,872 (6.4%)
Food & Beverage$426.05 (1.5%)
Education$146.24 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,578 | 14 | 77.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,170 | 2 | 14.3% |
| Travel and Lodging | $1,872 | 6 | 6.4% |
| Food and Beverage | $426.05 | 5 | 1.5% |
| Education | $146.24 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $7,726 | 7 | $0 (2023) |
| ADC Therapeutics America, Inc. | $6,655 | 6 | $0 (2022) |
| GENZYME CORPORATION | $5,892 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $3,123 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $1,918 | 2 | $0 (2024) |
| AbbVie Inc. | $1,225 | 1 | $0 (2020) |
| Celgene Corporation | $1,055 | 4 | $0 (2022) |
| Janssen Biotech, Inc. | $975.00 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $525.00 | 1 | $0 (2023) |
| Incyte Corporation | $99.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.00 | 1 | Janssen Scientific Affairs, LLC ($150.00) |
| 2023 | $10,576 | 10 | PFIZER INC. ($5,726) |
| 2022 | $13,960 | 13 | ADC Therapeutics America, Inc. ($6,643) |
| 2021 | $1,011 | 3 | Celgene Corporation ($1,000) |
| 2020 | $3,395 | 2 | GENZYME CORPORATION ($2,170) |
| 2017 | $99.00 | 1 | Incyte Corporation ($99.00) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | Janssen Scientific Affairs, LLC | TALVEY (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: Oncology | ||||||
| 08/17/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,482.00 | General |
| 08/15/2023 | PFIZER INC. | ELREXFIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: ONCOLOGY | ||||||
| 07/27/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 06/21/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,270.00 | General |
| 05/20/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $615.72 | General |
| 05/20/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $419.82 | General |
| 05/20/2023 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $358.07 | General |
| 05/20/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $162.01 | General |
| 05/18/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Consulting Fee | Cash or cash equivalent | $1,238.00 | General |
| Category: Oncology | ||||||
| 05/16/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,605.50 | General |
| 12/11/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $43.93 | General |
| 12/10/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $29.06 | General |
| Category: Hematology | ||||||
| 12/10/2022 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $26.05 | General |
| 12/09/2022 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Education | In-kind items and services | $35.84 | General |
| Category: Oncology | ||||||
| 12/05/2022 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: Oncology | ||||||
| 11/04/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 10/24/2022 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 10/24/2022 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $73.75 | General |
| 09/19/2022 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,440.00 | General |
| 08/13/2022 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $349.35 | General |
| 08/13/2022 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $165.00 | General |
| 08/13/2022 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $55.00 | General |
| 01/05/2022 | Janssen Scientific Affairs, LLC | DARZALEX (Drug) | Consulting Fee | Cash or cash equivalent | $1,767.50 | General |
| Category: Oncology | ||||||
| 12/22/2021 | ADC Therapeutics America, Inc. | — | Education | In-kind items and services | $11.40 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 255 | 370 | $107,306 | $25,800 |
| 2022 | 7 | 463 | 750 | $213,971 | $58,511 |
| 2021 | 8 | 453 | 804 | $219,333 | $66,099 |
| 2020 | 11 | 528 | 844 | $193,769 | $52,943 |
Total Patients
1,699
Total Services
2,768
Medicare Billing
$203,353
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 249 | $75,470 | $18,495 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 73 | $18,980 | $3,169 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,103 | $1,855 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,785 | $1,569 | 32.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 16 | $1,968 | $712.85 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 233 | 469 | $142,107 | $37,119 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $15,913 | $5,399 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 72 | $18,720 | $3,898 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 29 | $10,817 | $3,442 | 31.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 35 | 35 | $10,640 | $2,776 | 26.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 27 | 54 | $6,642 | $2,724 | 41.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 21 | 28 | $4,284 | $1,878 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 16 | $4,848 | $1,275 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 482 | $146,046 | $39,026 | 26.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 59 | 113 | $17,289 | $8,845 | 51.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 58 | $21,634 | $7,107 | 32.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $10,319 | $3,965 | 38.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 32 | 62 | $7,626 | $2,952 | 38.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 31 | $8,060 | $1,697 | 21.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,103 | $1,345 | 32.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 14 | 14 | $4,256 | $1,162 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 203 | 407 | $108,099 | $24,905 | 23.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 86 | 146 | $22,338 | $9,539 | 42.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 71 | 105 | $12,915 | $4,353 | 33.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 38 | 38 | $11,514 | $3,915 | 34.0% |
About Dr. Peter Barth, M.D
Dr. Peter Barth, M.D is a Internal Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1124382445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Barth, M.D has received a total of $29,192 in payments from pharmaceutical and medical device companies, with $150.00 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($22,578).
As a Medicare-enrolled provider, Barth has provided services to 1,699 Medicare beneficiaries, totaling 2,768 services with total Medicare billing of $203,353. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Providence, RI
- Active Since 07/02/2012
- Last Updated 06/09/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124382445
Products in Payments
- SARCLISA (Biological) $3,408
- DARZALEX (Drug) $1,768
- VENCLEXTA (Drug) $1,225
- TECVAYLI (Biological) $975.00
- ELREXFIO (Drug) $900.00
- CALQUENCE (Drug) $525.00
- Revlimid (Drug) $400.00
- TALVEY (Biological) $150.00
- SPRYCEL (Drug) $35.84
- Pomalyst (Drug) $29.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Providence
Randall Ingham, M.d, M.D
Internal Medicine — Payments: $154,470
Internal Medicine $154,470
Farah Moustafa, Md, MD
Internal Medicine — Payments: $50,984
Internal Medicine $50,984
Monica Dhakar, M.d, M.D
Internal Medicine — Payments: $47,405
Internal Medicine $47,405
Hajra Awwab, Md, MD
Internal Medicine — Payments: $41,418
Internal Medicine $41,418
Richard Ruggieri, M.d, M.D
Internal Medicine — Payments: $36,352
Internal Medicine $36,352
Jeffrey Lawrence, M.d, M.D
Internal Medicine — Payments: $23,037
Internal Medicine $23,037